NSN 6505-01-692-4087, 6505016924087
INFLUENZA VIRUS VACCINE

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016924087
Codification Country: United States
Item Name Code: INC 22781
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-692-4087

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-692-4087

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-692-4087

National Stock Number (NSN) 6505-01-692-4087, or NIIN 016924087, (influenza virus vaccine) was assigned December 11, 2020 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over a year. There have been 2 contracts issued for this part number, with 2 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP21F5781, SPE2DP21F2378. The total value of the awarded contracts has been US$ 2,864,452.84.

This NSN is assigned to Item Name Code (INC) 22781. [A VACCINE INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF INFLUENZA DISEASE CAUSED BY INFLUENZA A SUBTYPE VIRUSES AND TYPE B VIRUSES CONTAINED IN THE VACCINE.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016924087 does not contain precious metals.

This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.

This information was last updated on Aug 01, 2025.

Technical Characteristics

PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) INFLUENZA VIRUS VACCINE, QUADRIVALENT "FLUAD ADJUVANTED"
SPECIAL FEATURES: (FEAT) 0.5 ML PRE-FILLED SYRINGE; PG (10 S) (W/O NEEDLES). FOR FLU SEASON 2021-2022. FOR IMMUNIZING PERSONS 65 YEARS OF AGE AND OLDER; FOR IM ADMINISTRATION; PRESERVATIVE FREE; REQUIRES REFRIG BTWN 2-8 DEC C; DO NOT FREEZE. 2021-2022 STRAINS: A/WISCONSIN/588/2019 (H1N1)PDM09-LIKE VIRUS A/CAMBODIA/E0826360/2020 (H3N2)-LIKE VIRUS B/WASHINGTON/02/2019 (B/VICTORIA LINEAGE)-LIKE VIRUS B/PHUKET.